How does tirzepatide work?

Tirzepatide is a once-weekly injectable peptide. It works by copying two natural hormones your gut releases after a meal. Those hormones tell your body to handle blood sugar well and to feel full, so tirzepatide nudges the same signals: it helps your pancreas release insulin when blood sugar is high, slows digestion so food stays with you longer, and quiets appetite in the brain. Used alongside diet and activity, that adds up to better blood-sugar control and reduced appetite, which supports weight loss.

It is prescription-only, and whether it is right for you is a decision for a licensed provider. Results vary from person to person. No one can promise you a specific number.

A peptide is a short chain of amino acids, which are the building blocks of proteins. Your body makes thousands of them, and many act as chemical messengers that carry instructions from one part of the body to another. Tirzepatide is a synthetic peptide: it was engineered to look enough like two of your own hormone messengers that it can stand in for them and switch on the same receptors.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is also described as an incretin mimetic. Two terms worth unpacking:

• Incretins are gut hormones your body releases after you eat. They help manage the rise in blood sugar that follows a meal and signal fullness.
• Agonistmeans “something that activates a receptor.” A receptor is a docking point on a cell. When the right molecule docks, it switches the cell's response on.

So tirzepatide is a peptide that mimics incretin hormones and activates two of their receptors at once: the GIP receptor (glucose-dependent insulinotropic polypeptide) and the GLP-1 receptor (glucagon-like peptide-1). Activating both pathways together is what distinguishes it from medications that act on GLP-1 alone, the difference we cover in tirzepatide vs semaglutide.

Once tirzepatide activates the GIP and GLP-1 receptors, a few things happen across your pancreas, your stomach, and your brain. These are the main effects, described simply:

• Better insulin timing. It helps the pancreas release insulin when blood sugar is high. This is glucose-dependent, meaning it mainly kicks in when your blood sugar is up, rather than forcing insulin out at all times.
• Lower glucagon. It reduces glucagon, a hormone that raises blood sugar. Less glucagon plus better-timed insulin means steadier blood-sugar control.
• Slower digestion. It slows gastric emptying, the rate at which your stomach passes food along. Food stays with you longer, so you feel full longer after a meal.
• Reduced appetite. It acts on appetite-regulation centers in the brain to turn down hunger and reduce how much you eat.

Put those together and you get the combined result: improved blood-sugar control and a smaller appetite. Eating less, more comfortably, over time is what supports weight loss, and only when it is paired with sensible diet and activity. The medication does part of the work, not all of it. For a realistic look at outcomes, see how much weight you can lose on tirzepatide.

Tirzepatide is not begun at full strength. It is started at a low dose and increased gradually on an increasing-dose plan. Stepping up slowly gives your body time to adjust and helps limit the gastrointestinal side effects (mostly nausea) that are most noticeable as the dose rises. According to Eli Lilly prescribing information and peer-reviewed research, this gradual approach is standard for medications in this class. You can see the typical schedule on our tirzepatide dosage chart.

Crossing offers compounded tirzepatide, compounded with vitamin B6 and given as a weekly subcutaneous injection. It is manufactured by BPI Labs (an FDA-registered 503B facility in Largo, Florida, operating under cGMP) and dispensed by The Pharmacy Hub, a licensed 503A pharmacy. To start, you complete a roughly 10-minute online visit. If a provider licensed in your state determines it is appropriate, your medication ships to you. Tirzepatide is prescription-only.

For the medication itself, see the tirzepatide product details.